Nimbus Discovery preclinical data

Nimbus said ND-630 inhibited hepatic fatty acid synthesis with an ED50 of 0.14 mg/kg and stimulated whole body fatty acid oxidation at a minimum effective dose of 3 mg/kg in rats. Data were presented ...